Professional Documents
Culture Documents
January 2016
Disclosure Information
I have no financial relationships to
disclose.
Opinions are mine, not official positions
Alarmism in Science
Scientists
make
meaningless
or ambiguous
statements.
Politicians
respond to
alarm by feeding
scientist more
money
The media
translates
statements into
alarmist
declarations
public
Convey the strength of the evidence
Understand strengths and limitations of study designs
Report new findings in the context of existing
knowledge
Level II:
Level III:
2.
3.
4.
5.
Targets
Population(s)
2
Interventions
Intermediate
Endpoints
Health
Outcomes
4
Toxicities/
Harms
10
Persons
at Risk
Screening
Healthy
Early
Cancer
Detection
Adverse Effects
of Screening
Intermediate
Outcomes
Adverse
Effects
of Treatment
Health Outcomes
Cancer Mortality
Overall Mortality
Quality of Life
Societal Outcomes/
Trade Offs
Healthcare
Utilization
Cost Effectiveness
11
Symptoms
Screen detection
Lead
Time
Bias
Death
14
50
40
30
20
10
0
-100
Pearson r = .00
Spearman r = -.07
0
100
200
300
% Change in Mortality (1950-1996)
400
15
Surrogate
Endpoints
Very Important
Unclear Importance
! ! ! ! ! ! ! ! ! ! ! !..? ? ? ? ? ? ? ? ?
Fewer
deaths,
period
Fewer
deaths
due to
specific
disease
Fewer
complicat
ions of
disease
Fewer
diagnoses
of disease
Better
test
results
Change
in risk
factor
16
Confounding Variables
Exposure
Outcome
Confounder
Confounding is the death of any
study!
17
18
Confounding Variables
Fewer
accidents
Volvo
High SES
Safety conscious
?
Soccer mom
Age
19
Confounding Variables
Hormone
replacement
Lower rate of
heart disease
Health
consciousness
?
Health
insurance
Access to care
20
Confounding Variables
Vitamin/
Supplement
Intake
Lower rate of
Cancer, Heart
Disease
Health
consciousness
?
Health insurance
Access to care
Observational Studies
22
Randomized
Controlled Double
Blind Studies
Randomized
Controlled Studies
Cohort Studies
23
24
25
26
www.cancer.gov
www.cancer.gov/espanol